Navigation Links
HIV drug reduces graft-versus-host disease in stem cell transplant patients, Penn study shows
Date:12/13/2011
-related toxicities in these patients, nor did it alter the relapse rate of their underlying disease.
David Porter, MD, professor of Medicine and director of Blood and Marrow Transplantation in the Abramson Cancer Center, and Robert Vonderheide, MD, DPhil, associate professor of Medicine and Associate Director for Translational Research at the Abramson Cancer Center, are the senior authors of the study.
'/>"/>
| Contact: Holly Auer holly.auer@uphs.upenn.edu 215-200-2313 University of Pennsylvania School of Medicine Source:Eurekalert |
Related medicine news :
1. Service Foods Reduces its Carbon Footprint and Grows Sales
2. Health Care Reform Report Covers Uninsured, Reduces Costs
3. New cardiac CT technology drastically reduces patient radiation exposure
4. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
5. Targeted delivery of losartan reduces liver inflammation and scarring
6. Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
7. Soccer reduces risk of falls and bone fractures
8. Pioneering treatment reduces disability in premature babies with serious brain hemorrhage
9. New drug candidate reduces blood lipids
10. PSA Test Reduces Prostate Cancer Deaths by 40%
11. New technique reduces tobacco smoke damage to lungs in mice
Post Your Comments:
(Date:6/18/2013)... 2013 Healthcare Solutions , ... Procura Management, today announced the appointment of Richard ... In this position, Leonardo will direct Healthcare Solutions’ ... strategic growth initiatives. , Recognized in the property ... Leonardo brings more than 20 years of experience ...
(Date:6/18/2013)... 18, 2013 New York magazine named 145 ... its “Best Doctors” list, up from 129 last year and ... new issue also lists 52 additional doctors who serve at ... strategic growth trajectory. The “Best Doctors” issue, which this year ... 24 print issue and is available online at http://www.nymag.com/bestdoctors ...
(Date:6/18/2013)... at University Hospitals Case Medical Center enrolled their first ... trial evaluating a novel, less-invasive procedure to help clear ... Every year, more than 300,000 people in the United ... carotid artery. If left untreated, these blockages can slow ... a potentially disabling stroke, also known as a "brain ...
(Date:6/18/2013)... Medicare penalties on hospitals with higher-than-expected rates of ... hospitals are evaluating the most accurate methods for ... appearing in the June issue of the ... finds that the American College of Surgeons National ... more accurate data tracking than another popular database, ...
(Date:6/18/2013)... Atlanta, GA (PRWEB) June 18, 2013 ... founder of the Atlanta Vision Institute, is pleased to ... the next generation of Intralase LASIK equipment, the iFS™ ... the only LASIK practice in Atlanta to offer its ... Dr. Ashraf is giving his patients a complimentary upgrade ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 3Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 4Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2[0] Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer[0] Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue[0] UH Case Medical Center among first to enroll patients for global carotid artery trial[0] ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions[0] Atlanta LASIK Surgeon Offers New LASIK Technology
... (Nasdaq: HSKA ) announces the following Webcast: , What: ... Year-End 2008 Earnings Conference Call on the ... (MST], Where: www.heska.com (click on the Q4 and Year-End 2008 ... on the front page of this website)., How: ...
... University and Baxter Healthcare Corporation will create a ... announced today. , Under the three-year renewable agreement, ... levels for each year may reach approximately $1 ... levels on a case-by-case basis. Aligned with Baxter,s ...
... French . -->, ,Researchers ... Health Centre (RI MUHC) and the McGill University and Gnome ... Belgian institutions, have discovered DNA variations in a gene that ... in the January issue of the journal Nature Genetics ...
... Jan. 8 /PRNewswire-USNewswire/ -- Advocates for ... and reproductive health, has released an analysis showing ... lag far behind those in France, Germany, and ... , The U.S. teen birth rate, for example, ...
... Health Information Community brings together public-private sector ... networkWASHINGTON, Jan. 8 The National eHealth ... launched today in Washington, D.C. The ... dedicated to the creation of a secure, ...
... could indicate an epidemic of skin cancer, researchers suggest ... of the deadly skin cancer melanoma are increasing among ... older men, researchers report. , Whether the increase in ... However, the rate is increasing among all Americans and ...
Cached Medicine News:Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Baxter and Northwestern University partner to target new life sciences projects 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 3Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 2Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 3Health News:National eHealth Collaborative Launched 2Health News:National eHealth Collaborative Launched 3Health News:National eHealth Collaborative Launched 4Health News:National eHealth Collaborative Launched 5Health News:National eHealth Collaborative Launched 6Health News:Melanoma Rates on the Rise in U.S. 2Health News:Melanoma Rates on the Rise in U.S. 3Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call WebcastBaxter and Northwestern University partner to target new life sciences projectsMcGill researchers discover gene that increases susceptibility to Crohn's diseaseU.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based ApproachNational eHealth Collaborative LaunchedMelanoma Rates on the Rise in U.S.
(Date:6/18/2013)... -- Royal Philips (NYSE: PHG, AEX: PHIA) ... in Imaging Equipment in the 2013 Best in KLAS ... Best in KLAS and Best in Category awards for ... Computed Tomography (CT), Ingenia 1.5T and 3.0T Magnetic Resonance ... Best in KLAS Awards: Medical Imaging & Infrastructure are ...
(Date:6/18/2013)... YORK, Pa. , June 18, 2013 ... a U.S. based designer, developer and manufacturer of injectable ... new corporate website at www.unilife.com . The new ... information, with updates to occur on a regular basis. ... of Unilife, stated, "As an emerging global leader for ...
(Date:6/18/2013)... Calif. , June 18, 2013 Women are ... families, but unfortunately they often do not give the ... women have kept information from their doctor because they ... it, according to a recent survey conducted by Allergan ... organization dedicated to bringing education, funding and research to ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9... Dec. 10 The US Food and,Drug Administration ... small,open, long-term, clinical studies in patients with gastro-esophageal ... study) or NEXIUM(R) (LOTUS study) treatment., AstraZeneca ... conclusion which states,"FDA continues to conclude that long-term ...
... 3 Results Released at American Society of Hematology ... Genta,Incorporated (Nasdaq: GNTA ) announced the release ... patients in the Company,s randomized Phase,3 trial of ... lymphocytic leukemia (CLL). The new data show that,patients ...
Cached Medicine Technology:FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 6... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |